US Map / Idaho
State ID

Clinical Trials in Idaho

Idaho is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Idaho and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 60 actively recruiting studies with Idaho sites out of 60 registered in total. The busiest research areas in Idaho are Obesity, Hypertension, Overweight. Leading sponsors running trials in the state include National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network. By stage, Idaho trials break down as Phase 1 (4), Phase 2 (16), Phase 3 (30).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
60
Recruiting Now
60
← Back to US Map
Top Conditions in Idaho
Obesity (3)Hypertension (2)Overweight (2)Acute Myeloid Leukemia (2)Type 2 Diabetes Mellitus (2)Diabetes Mellitus, Type 2 (2)Lung Non-Small Cell Carcinoma (2)HPV (1)HPV - Anogenital Human Papilloma Virus Infection (1)Surgical Wound Infection (1)Traumatic Wound Infection (1)Metastatic Castration-Resistant Prostate Carcinoma (1)

Frequently Asked Questions — Clinical Trials in Idaho

How many clinical trials are currently recruiting in Idaho?
ClinicalMetric currently tracks 60 actively recruiting clinical trials with at least one location in Idaho. The total number of registered studies—including active but not currently enrolling trials—is 60. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Idaho?
Idaho hosts clinical trials across a broad range of medical conditions, including Obesity, Hypertension, Overweight, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Idaho serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Idaho?
To join a clinical trial in Idaho, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Idaho maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Idaho

NCT05677490 Phase 3
Recruiting
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanc...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
382 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06775379 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Condition
Major Depressive Disorder
Enrollment
450 pts
Location
United States
Sponsor
Xenon Pharmaceuticals Inc.
View Trial →
NCT07013474 Phase 3
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 W...
Condition
COVID-19 Infection
Enrollment
300 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
View Trial →
NCT04239573 N/A
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Assoc...
Condition
Pancreatic Neoplasm
Enrollment
770 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07018869 Phase 3
Recruiting
Evaluating Whether an Educational Website Called Current Together After Cancer (...
Condition
Colorectal Cancer Stage II
Enrollment
1,057 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06382155 Phase 2
Recruiting
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Condition
Idiopathic Short Stature
Enrollment
100 pts
Location
United States, Australia, France
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06237452 Phase 3
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Condition
Clostridium Difficile
Enrollment
852 pts
Location
United States, Australia, Belgium
Sponsor
Vedanta Biosciences, Inc.
View Trial →
NCT07391774 Phase 3
Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy ...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
1,978 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05655182 Phase 1, Phase 2
Recruiting
A Study of BLB-201 RSV Vaccine in Infants and Children
Condition
Respiratory Syncytial Virus Infections
Enrollment
137 pts
Location
United States
Sponsor
Blue Lake Biotechnology Inc.
View Trial →
NCT06578195 N/A
Recruiting
ASSESS ALL ALS Study
Condition
Amyotrophic Lateral Sclerosis
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
St. Joseph's Hospital and Medi
View Trial →
NCT06917911 Phase 2
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatm...
Condition
Core Binding Factor Acute Myeloid Leukemia
Enrollment
162 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07743450 Phase 3
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Pa...
Condition
Obesity
Enrollment
1,560 pts
Location
United States, Czechia, Germany
Sponsor
Ascletis Pharma (China) Co., L
View Trial →
NCT07521475 N/A
Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Condition
Type 2 Diabetes Mellitus
Enrollment
350 pts
Location
United States
Sponsor
Insulet Corporation
View Trial →
NCT06246916 Phase 3
Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Partic...
Condition
Melanoma
Enrollment
560 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07415954 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419...
Condition
Diabetes Mellitus, Type 2
Enrollment
270 pts
Location
United States, Croatia, Hungary
Sponsor
Novo Nordisk A/S
View Trial →
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT07446322 Phase 2
Recruiting
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of ...
Condition
Ras-mutated Metastatic Colorectal Cancer
Enrollment
60 pts
Location
United States
Sponsor
Oncolytics Biotech
View Trial →
NCT02071134 N/A
Recruiting
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registr...
Condition
Parkinson's Disease
Enrollment
1,500 pts
Location
United States, Argentina, Austria
Sponsor
Boston Scientific Corporation
View Trial →
NCT05099003 Phase 1, Phase 2
Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diag...
Condition
Malignant Glioma
Enrollment
132 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT07388524 Phase 3
Recruiting
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Preven...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
336 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06116682 Phase 2
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Co...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
88 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT03664609 N/A
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Condition
Parkinson Disease
Enrollment
5,000 pts
Location
United States, Belgium, France
Sponsor
Boston Scientific Corporation
View Trial →
Page 2 of 3 — 60 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology